These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
316 related items for PubMed ID: 22325689
1. Comparison of antibiotic susceptibility patterns in Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) with invasive Pseudomonas aeruginosa from non-CF patients. Rao P, McCaughan J, McCalmont M, Goldsmith CE, Hall V, Millar BC, McCann MA, Downey DG, Rendall JC, Elborn JS, Moore JE. J Cyst Fibros; 2012 Jul; 11(4):349-52. PubMed ID: 22325689 [No Abstract] [Full Text] [Related]
2. Direct comparison of in vitro susceptibility of wildtype clinical Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) to TOBI and BRAMITOB (tobramycin inhalation solutions). Moore JE, Maeda Y, Goldsmith CE, Rendall JC, Elborn JS. J Cyst Fibros; 2010 May; 9(3):237-8. PubMed ID: 20378421 [No Abstract] [Full Text] [Related]
3. Consequences of combining cystic fibrosis- and non-cystic fibrosis-derived Pseudomonas aeruginosa antibiotic susceptibility results in hospital antibiograms. Bosso JA, Mauldin PD, Steed LL. Ann Pharmacother; 2006 Nov; 40(11):1946-9. PubMed ID: 17018687 [Abstract] [Full Text] [Related]
4. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population. Bradbury R, Champion A, Reid DW. Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887 [Abstract] [Full Text] [Related]
7. Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis. Ferroni A, Guillemot D, Moumile K, Bernede C, Le Bourgeois M, Waernessyckle S, Descamps P, Sermet-Gaudelus I, Lenoir G, Berche P, Taddei F. Pediatr Pulmonol; 2009 Aug; 44(8):820-5. PubMed ID: 19598278 [Abstract] [Full Text] [Related]